A key opinion leader examines how the introduction of biologic therapies revolutionized atopic dermatitis treatment, addressing strategies to manage patients' concerns about needles and injections.
How have the emergence of biologics changed the treatment landscape of these diseases caused by an overactive immune response?
How do you approach presenting monoclonal antibody treatments to patients or caregivers who have an apprehension of needles or injections? What strategies do you use to alleviate their concerns and gain their trust in proceeding with this preferred treatment option?